ORLANDO, Fla. — The diabetes and weight loss drug tirzepatide (Mounjaro for type 2 diabetes; Zepbound for obesity) was so effective at reducing sleep disruptions in patients with obesity and ...
Share on Pinterest A clinical trial shows that Zepbound and Mounjaro reduced obstructive sleep apnea symptoms in people with obesity. NurPhoto/Getty Images Around 70% of people who have obstructive ...
The weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea ...
When you think of people with sleep apnea, maybe you picture loud, cartoonish snoring, or assume you’d know something was wrong because you’d wake up feeling completely wiped out every morning. But ...
Sleep apnea is a condition that causes breathing to stop and start repeatedly while sleeping. It may occur up to 400 times per night, with each pause lasting 10 seconds or longer. There are two main ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results